Functional characterization of a novel transcript of ERCC1 in chemotherapy resistance of ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Functional characterization of a novel transcript of ERCC1 in chemotherapy resistance of ovarian cancer

Published:2017-08-24 Issue:49 Volume:8 Page:85759-85771
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Liu Jia¹,Zhang Lin²,Mao Ping³,Jiang Guoqiang¹,Liu Likun¹,Wang Jing¹,Yang Wei⁴,Owusu Lawrence¹⁵,Li Weiling¹

Affiliation:

1. Department of Biotechnology, Dalian Medical University, Dalian, Liaoning, 116044, China

2. Academy of Integrative Medicine, Dalian Medical University, Dalian, Liaoning, 116044, China

3. Department of General Surgery, The People’s Hospital of Liaoning Province, Shenyang, Liaoning, 110016, China

4. Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Sheng 450000, China

5. Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL 33612, USA

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. XPF–ERCC1 Blocker Improves the Therapeutic Efficacy of 5-FU- and Oxaliplatin-Based Chemoradiotherapy in Colorectal Cancer;Cells;2023-05-25

2. XPF-ERCC1 blocker improves the therapeutic efficacy of 5-FU- and oxaliplatin-based chemoradiotherapy in rectal cancer;2022-12-05

3. COM33 suppresses carboplatin-induced epithelial-mesenchymal transition via inhibition of Twist1 in ovarian cancer;Acta Biochimica et Biophysica Sinica;2022-12-01

4. Influence of clinical and molecular genetic characteristics on the first relapse-free period in patients with glioblastoma in the era of modern chemoradiotherapy;Russian Journal for Personalized Medicine;2022-09-16

5. Therapeutic strategies to overcome cisplatin resistance in ovarian cancer;European Journal of Medicinal Chemistry;2022-03

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3